The CJC-1295/Ipamorelin combination represents one of the most extensively studied peptide pairs in growth hormone axis research. By pairing a GHRH analog with a selective GH secretagogue, this combination engages two independent receptor pathways that converge on pituitary somatotroph cells to stimulate GH release.
Access verified quality documentation and research-grade peptides.
View Certificates of Analysis Explore Research-Grade PeptidesDisclaimer: All compounds referenced in this article are intended for laboratory research use only. They are not approved for human or veterinary use by the FDA or any regulatory agency.